The Scientist

» election

Most Recent

image: Science and Politics in 2012

Science and Politics in 2012

By | December 19, 2012

This year, US politics was dominated by the run-up to October elections, with science policy issues playing a role here and elsewhere around the world.

1 Comment

image: Science and the 2012 Election

Science and the 2012 Election

By | November 8, 2012

From education to space, science fared well at the polls on Tuesday.

0 Comments

image: Industry Donates Big This Election

Industry Donates Big This Election

By | November 6, 2012

Biotech, pharmaceutical, and insurance companies have spent a record-breaking amount this election—nearly $200 million.

0 Comments

image: Q&A: Mixing Science and Politics

Q&A: Mixing Science and Politics

By | October 9, 2012

Politicians could make better decisions if they thought more like scientists, says Rush Holt, the only physicist in Congress.  

1 Comment

image: US Voters Oppose Science Cuts

US Voters Oppose Science Cuts

By | September 24, 2012

Many Americans who are likely to vote in upcoming elections are not in favor of across-the-board cuts to non-discretionary funding.

3 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham